As children return to area schools this month, here are some points of interest about the delta COVID variant from experts at UT Health San Antonio.

In a sample of more than 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment.

Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.

We at UT Health San Antonio are closely monitoring the recent increase in community prevalence and transmission of the COVID-19 virus. At present, elsewhere and here in San Antonio, the latest surge is predominantly related to spread by the COVID delta variant. The delta variant is about four times more contagious than the original alpha variant and two times more lethal for unvaccinated people. Given the marked increase in community prevalence and spread, it is prudent that we increase our preventive protocols so that we can continue to keep on-campus transmission rates low.

Our biochemistry team learns more about how the coronavirus disguises itself in the body.